{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:19:10Z","timestamp":1711415950188},"posted":{"date-parts":[[2023,12,19]]},"group-title":"In Review","reference-count":98,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,12,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Mutations in myocilin <jats:bold>(<\/jats:bold><jats:italic>MYOC<\/jats:italic>) are the leading known genetic cause of primary open-angle glaucoma, responsible for about 4% of all cases. Mutations in <jats:italic>MYOC<\/jats:italic> cause a gain-of-function phenotype in which mutant myocilin accumulates in the endoplasmic reticulum (ER) leading to ER stress and trabecular meshwork (TM) cell death. Therefore, knocking out myocilin at the genome level is an ideal strategy to permanently cure the disease. We have previously utilized CRISPR\/Cas9 genome editing successfully to target <jats:italic>MYOC<\/jats:italic> using adenovirus 5 (Ad5). However, Ad5 is not a suitable vector for clinical use. Here, we sought to determine the efficacy of adeno-associated viruses (AAVs) and lentiviruses (LVs) to target the TM. First, we examined the TM tropism of single-stranded (ss) and self-complimentary (sc) AAV serotypes as well as LV expressing GFP via intravitreal (IVT) and intracameral (IC) injections. We observed that LV_<jats:italic>GFP<\/jats:italic> expression was more specific to the TM injected via the IVT route. IC injections of Trp-mutant scAAV2 showed a prominent expression of GFP in the TM. However, robust GFP expression was also observed in the ciliary body and retina. We next constructed lentiviral particles expressing Cas9 and guide RNA (gRNA) targeting <jats:italic>MYOC<\/jats:italic> (<jats:italic>crMYOC<\/jats:italic>) and transduction of TM cells stably expressing mutant myocilin with LV_cr<jats:italic>MYOC<\/jats:italic> significantly reduced myocilin accumulation and its associated chronic ER stress. A single IVT injection of LV_cr<jats:italic>MYOC<\/jats:italic> in <jats:italic>Tg-MYOC<\/jats:italic><jats:sup><jats:italic>Y437H<\/jats:italic><\/jats:sup> mice decreased myocilin accumulation in TM and reduced elevated IOP significantly. Together, our data indicates, LV_cr<jats:italic>MYOC<\/jats:italic> targets <jats:italic>MYOC<\/jats:italic> gene editing in TM and rescues a mouse model of myocilin-associated glaucoma.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3740880\/v1","type":"posted-content","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T19:47:45Z","timestamp":1703015265000},"source":"Crossref","is-referenced-by-count":0,"title":["Lentiviral mediated delivery of CRISPR\/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma"],"prefix":"10.21203","author":[{"given":"Shruti V.","family":"Patil","sequence":"first","affiliation":[{"name":"University of North Texas Health Science Center at Fort Worth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balasankara Reddy","family":"Kaipa","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Ranshing","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center at Fort Worth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogapriya","family":"Sundaresan","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Cameron","family":"Millar","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center at Fort Worth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavani","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center at Fort Worth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Kiehlbauch","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center at Fort Worth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"University of Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Jain","sequence":"additional","affiliation":[{"name":"University of Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Searby","sequence":"additional","affiliation":[{"name":"University of Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd E.","family":"Scheetz","sequence":"additional","affiliation":[{"name":"University of Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbot F.","family":"Clark","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center at Fort Worth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val C.","family":"Sheffield","sequence":"additional","affiliation":[{"name":"University of Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulab S.","family":"Zode","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley HA","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137. Epub 2006\/02\/21. doi: 10.1136\/bjo.2005.081224. PubMed PMID: 16488940; PMCID: PMC1856963.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"ref2","first-page":"323","article-title":"The global impact of glaucoma","volume":"72","author":"Thylefors B","year":"1994","unstructured":"Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Organ. 1994;72(3):323\u20136. Epub 1994\/01\/01. PubMed PMID: 8062393; PMCID: PMC2486713.","journal-title":"Bull World Health Organ"},{"issue":"11","key":"ref3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390. Epub 2014\/07\/01. doi: 10.1016\/j.ophtha.2014.05.013. PubMed PMID: 24974815.","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"publisher","first-page":"S151-61","DOI":"10.1016\/s0039-6257(99)00029-6","article-title":"Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death","volume":"43","author":"Nickells RW","year":"1999","unstructured":"Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol. 1999;43 Suppl 1:S151-61. Epub 1999\/07\/23. doi: 10.1016\/s0039-6257(99)00029-6. PubMed PMID: 10416758.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","article-title":"Neuronal death in glaucoma","volume":"18","author":"Quigley HA","year":"1999","unstructured":"Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18(1):39\u201357. Epub 1999\/01\/27. doi: 10.1016\/s1350-9462(98)00014-7. PubMed PMID: 9920498.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-016-1609-2","article-title":"Glaucoma: the retina and beyond","volume":"132","author":"Davis BM","year":"2016","unstructured":"Davis BM, Crawley L, Pahlitzsch M, Javaid F, Cordeiro MF. Glaucoma: the retina and beyond. Acta Neuropathol. 2016;132(6):807\u201326. Epub 2016\/08\/22. doi: 10.1007\/s00401-016-1609-2. PubMed PMID: 27544758; PMCID: PMC5106492.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"Kwon YH","year":"2009","unstructured":"Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009;360(11):1113\u201324. Epub 2009\/03\/13. doi: 10.1056\/NEJMra0804630. PubMed PMID: 19279343; PMCID: PMC3700399.","journal-title":"N Engl J Med"},{"issue":"7","key":"ref8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/s0161-6420(83)34492-4","article-title":"Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations","volume":"90","author":"Rohen JW","year":"1983","unstructured":"Rohen JW. Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations. Ophthalmology. 1983;90(7):758\u201365. Epub 1983\/07\/01. doi: 10.1016\/s0161-6420(83)34492-4. PubMed PMID: 6413918.","journal-title":"Ophthalmology"},{"issue":"18","key":"ref9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb RN","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901\u201311. Epub 2014\/05\/16. doi: 10.1001\/jama.2014.3192. PubMed PMID: 24825645; PMCID: PMC4523637.","journal-title":"JAMA"},{"issue":"9","key":"ref10","first-page":"1937","article-title":"Open-angle glaucoma","volume":"67","author":"Distelhorst JS","year":"2003","unstructured":"Distelhorst JS, Hughes GM. Open-angle glaucoma. Am Fam Physician. 2003;67(9):1937\u201344. Epub 2003\/05\/20. PubMed PMID: 12751655.","journal-title":"Am Fam Physician"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.04.029","author":"Braunger BM","year":"2015","unstructured":"Braunger BM, Fuchshofer R, Tamm ER. The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment. Eur J Pharm Biopharm. 2015;95(Pt B):173\u2009\u2013\u200981. Epub 2015\/05\/11. doi: 10.1016\/j.ejpb.2015.04.029. PubMed PMID: 25957840."},{"issue":"10","key":"ref12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/eye.2015.160","article-title":"Genes, pathways, and animal models in primary open-angle glaucoma","volume":"29","author":"Iglesias AI","year":"2015","unstructured":"Iglesias AI, Springelkamp H, Ramdas WD, Klaver CC, Willemsen R, van Duijn CM. Genes, pathways, and animal models in primary open-angle glaucoma. Eye (Lond). 2015;29(10):1285\u201398. Epub 2015\/09\/01. doi: 10.1038\/eye.2015.160. PubMed PMID: 26315706; PMCID: PMC4815694.","journal-title":"Eye (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.exer.2017.05.002","article-title":"Major review: Molecular genetics of primary open-angle glaucoma","volume":"160","author":"Liu Y","year":"2017","unstructured":"Liu Y, Allingham RR. Major review: Molecular genetics of primary open-angle glaucoma. Exp Eye Res. 2017;160:62\u201384. Epub 2017\/05\/14. doi: 10.1016\/j.exer.2017.05.002. PubMed PMID: 28499933; PMCID: PMC5557663.","journal-title":"Exp Eye Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2000.127","author":"Alward WL","year":"2000","unstructured":"Alward WL. The genetics of open-angle glaucoma: the story of GLC1A and myocilin. Eye (Lond). 2000;14 (Pt 3B):429\u2009\u2013\u200936. Epub 2000\/10\/12. doi: 10.1038\/eye.2000.127. PubMed PMID: 11026970."},{"issue":"10108","key":"ref15","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"Jonas JB","year":"2017","unstructured":"Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183\u201393. Epub 2017\/06\/05. doi: 10.1016\/S0140-6736(17)31469-1. PubMed PMID: 28577860.","journal-title":"Lancet"},{"issue":"5300","key":"ref16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1126\/science.275.5300.668","article-title":"Identification of a gene that causes primary open angle glaucoma","volume":"275","author":"Stone EM","year":"1997","unstructured":"Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275(5300):668\u201370. Epub 1997\/01\/31. doi: 10.1126\/science.275.5300.668. PubMed PMID: 9005853.","journal-title":"Science"},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng0593-47","article-title":"Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31","volume":"4","author":"Sheffield VC","year":"1993","unstructured":"Sheffield VC, Stone EM, Alward WL, Drack AV, Johnson AT, Streb LM, Nichols BE. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet. 1993;4(1):47\u201350. Epub 1993\/05\/01. doi: 10.1038\/ng0593-47. PubMed PMID: 8513321.","journal-title":"Nat Genet"},{"issue":"2","key":"ref18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0014-5793(97)00934-4","article-title":"Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin","volume":"413","author":"Ortego J","year":"1997","unstructured":"Ortego J, Escribano J, Coca-Prados M. Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett. 1997;413(2):349\u201353. Epub 1997\/08\/18. doi: 10.1016\/s0014-5793(97)00934-4. PubMed PMID: 9280311.","journal-title":"FEBS Lett"},{"issue":"7","key":"ref19","first-page":"974","article-title":"Myocilin and glaucoma: A TIGR by the tail?","volume":"118","author":"Johnson DH","year":"2000","unstructured":"Johnson DH. Myocilin and glaucoma: A TIGR by the tail? Arch Ophthalmol. 2000;118(7):974\u20138. Epub 2000\/07\/19. PubMed PMID: 10900113.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0002-9394(00)00536-5","article-title":"Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma","volume":"130","author":"Shimizu S","year":"2000","unstructured":"Shimizu S, Lichter PR, Johnson AT, Zhou Z, Higashi M, Gottfredsdottir M, Othman M, Moroi SE, Rozsa FW, Schertzer RM, Clarke MS, Schwartz AL, Downs CA, Vollrath D, Richards JE. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol. 2000;130(2):165\u201377. Epub 2000\/09\/27. doi: 10.1016\/s0002-9394(00)00536-5. PubMed PMID: 11004290.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"ref21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/hmg\/8.5.899","article-title":"Analysis of myocilin mutations in 1703 glaucoma patients from five different populations","volume":"8","author":"Fingert JH","year":"1999","unstructured":"Fingert JH, Heon E, Liebmann JM, Yamamoto T, Craig JE, Rait J, Kawase K, Hoh ST, Buys YM, Dickinson J, Hockey RR, Williams-Lyn D, Trope G, Kitazawa Y, Ritch R, Mackey DA, Alward WL, Sheffield VC, Stone EM. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8(5):899\u2013905. Epub 1999\/04\/10. doi: 10.1093\/hmg\/8.5.899. PubMed PMID: 10196380.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s1350-9462(02)00010-1","article-title":"Myocilin and glaucoma: facts and ideas","volume":"21","author":"Tamm ER","year":"2002","unstructured":"Tamm ER. Myocilin and glaucoma: facts and ideas. Prog Retin Eye Res. 2002;21(4):395\u2013428. Epub 2002\/08\/02. doi: 10.1016\/s1350-9462(02)00010-1. PubMed PMID: 12150989.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.18782\/2320-7051.2189","article-title":"Myocilin and Glaucoma its Risk Factors","volume":"4","author":"Lohano MK","year":"2016","unstructured":"Lohano MK, Su L, Ruochen W, Basnet BB, Naveed H, Khemani VD, Khooharo AA. Myocilin and Glaucoma its Risk Factors. Int J Pure App Biosci. 2016;4(1):15\u201323. doi: 10.18782\/2320-7051.2189.","journal-title":"Int J Pure App Biosci"},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1021\/acs.jmedchem.5b00828","article-title":"Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions","volume":"59","author":"Donegan RK","year":"2016","unstructured":"Donegan RK, Lieberman RL. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions. J Med Chem. 2016;59(3):788\u2013809. Epub 20150925. doi: 10.1021\/acs.jmedchem.5b00828. PubMed PMID: 26356532; PMCID: PMC5547565.","journal-title":"J Med Chem"},{"key":"ref25","author":"Sharma R","year":"2021","unstructured":"Sharma R, Grover A. Myocilin-associated Glaucoma: A Historical Perspective and Recent Research Progress. Mol Vis. 2021;27:480\u2009\u2013\u200993. Epub 2021\/09\/10. PubMed PMID: 34497454; PMCID: PMC8403517."},{"issue":"3","key":"ref26","first-page":"729","article-title":"Localization of myocilin\/trabecular meshwork\u2013inducible glucocorticoid response protein in the human eye","volume":"41","author":"Karali A","year":"2000","unstructured":"Karali A, Russell P, Stefani FH, Tamm ER. Localization of myocilin\/trabecular meshwork\u2013inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci. 2000;41(3):729\u201340. Epub 2000\/03\/11. PubMed PMID: 10711688.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1006\/geno.1997.4682","article-title":"A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping","volume":"41","author":"Kubota R","year":"1997","unstructured":"Kubota R, Noda S, Wang Y, Minoshima S, Asakawa S, Kudoh J, Mashima Y, Oguchi Y, Shimizu N. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics. 1997;41(3):360\u20139. Epub 1997\/05\/01. doi: 10.1006\/geno.1997.4682. PubMed PMID: 9169133.","journal-title":"Genomics"},{"issue":"1","key":"ref28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/bbrc.1998.8917","article-title":"Mouse myocilin (Myoc) gene expression in ocular tissues","volume":"248","author":"Takahashi H","year":"1998","unstructured":"Takahashi H, Noda S, Imamura Y, Nagasawa A, Kubota R, Mashima Y, Kudoh J, Oguchi Y, Shimizu N. Mouse myocilin (Myoc) gene expression in ocular tissues. Biochem Biophys Res Commun. 1998;248(1):104\u20139. Epub 1998\/07\/24. doi: 10.1006\/bbrc.1998.8917. PubMed PMID: 9675094.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"ref29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1101\/gr.8.4.377","article-title":"Characterization and comparison of the human and mouse GLC1A glaucoma genes","volume":"8","author":"Fingert JH","year":"1998","unstructured":"Fingert JH, Ying L, Swiderski RE, Nystuen AM, Arbour NC, Alward WL, Sheffield VC, Stone EM. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 1998;8(4):377\u201384. Epub 1998\/06\/13. doi: 10.1101\/gr.8.4.377. PubMed PMID: 9548973; PMCID: PMC310708.","journal-title":"Genome Res"},{"issue":"2","key":"ref30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3892\/ijmm.2018.3992","article-title":"Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review)","volume":"43","author":"Wang H","year":"2019","unstructured":"Wang H, Li M, Zhang Z, Xue H, Chen X, Ji Y. Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review). Int J Mol Med. 2019;43(2):671\u201381. Epub 2018\/11\/30. doi: 10.3892\/ijmm.2018.3992. PubMed PMID: 30483726; PMCID: PMC6317685.","journal-title":"Int J Mol Med"},{"issue":"6","key":"ref31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0039-6257(02)00353-3","article-title":"Myocilin glaucoma","volume":"47","author":"Fingert JH","year":"2002","unstructured":"Fingert JH, Stone EM, Sheffield VC, Alward WL. Myocilin glaucoma. Surv Ophthalmol. 2002;47(6):547\u201361. Epub 2002\/12\/31. doi: 10.1016\/s0039-6257(02)00353-3. PubMed PMID: 12504739.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"ref32","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.exer.2008.08.011","article-title":"Glaucoma-associated myocilin: a better understanding but much more to learn","volume":"88","author":"Resch ZT","year":"2009","unstructured":"Resch ZT, Fautsch MP. Glaucoma-associated myocilin: a better understanding but much more to learn. Exp Eye Res. 2009;88(4):704\u201312. Epub 2008\/09\/23. doi: 10.1016\/j.exer.2008.08.011. PubMed PMID: 18804106; PMCID: PMC2682697.","journal-title":"Exp Eye Res"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1167\/iovs.09-4866","article-title":"Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications","volume":"52","author":"Aroca-Aguilar JD","year":"2011","unstructured":"Aroca-Aguilar JD, Sanchez-Sanchez F, Ghosh S, Fernandez-Navarro A, Coca-Prados M, Escribano J. Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications. Invest Ophthalmol Vis Sci. 2011;52(1):179\u201389. Epub 2010\/10\/12. doi: 10.1167\/iovs.09-4866. PubMed PMID: 20926826; PMCID: PMC3053273.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179989","author":"Atienzar-Aroca R","year":"2022","unstructured":"Atienzar-Aroca R, Ferre-Fernandez JJ, Tevar A, Bonet-Fernandez JM, Cabanero MJ, Ruiz-Pastor MJ, Cuenca N, Aroca-Aguilar JD, Escribano J. Transgenic Overexpression of Myocilin Leads to Variable Ocular Anterior Segment and Retinal Alterations Associated with Extracellular Matrix Abnormalities in Adult Zebrafish. Int J Mol Sci. 2022;23(17). Epub 20220901. doi: 10.3390\/ijms23179989. PubMed PMID: 36077382; PMCID: PMC9456529."},{"issue":"2","key":"ref35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/hmg\/10.2.117","article-title":"Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor","volume":"10","author":"Jacobson N","year":"2001","unstructured":"Jacobson N, Andrews M, Shepard AR, Nishimura D, Searby C, Fingert JH, Hageman G, Mullins R, Davidson BL, Kwon YH, Alward WL, Stone EM, Clark AF, Sheffield VC. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10(2):117\u201325. Epub 2001\/01\/12. doi: 10.1093\/hmg\/10.2.117. PubMed PMID: 11152659.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"ref36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/hmg\/ddh128","article-title":"Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma","volume":"13","author":"Liu Y","year":"2004","unstructured":"Liu Y, Vollrath D. Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum Mol Genet. 2004;13(11):1193\u2013204. Epub 2004\/04\/08. doi: 10.1093\/hmg\/ddh128. PubMed PMID: 15069026.","journal-title":"Hum Mol Genet"},{"issue":"22","key":"ref37","doi-asserted-by":"publisher","first-page":"21043","DOI":"10.1074\/jbc.M501340200","article-title":"Myocilin mutations causing glaucoma inhibit the intracellular endoproteolytic cleavage of myocilin between amino acids Arg226 and Ile227","volume":"280","author":"Aroca-Aguilar JD","year":"2005","unstructured":"Aroca-Aguilar JD, Sanchez-Sanchez F, Ghosh S, Coca-Prados M, Escribano J. Myocilin mutations causing glaucoma inhibit the intracellular endoproteolytic cleavage of myocilin between amino acids Arg226 and Ile227. J Biol Chem. 2005;280(22):21043\u201351. Epub 2005\/03\/30. doi: 10.1074\/jbc.M501340200. PubMed PMID: 15795224.","journal-title":"J Biol Chem"},{"issue":"3","key":"ref38","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1006\/bbrc.2001.4624","article-title":"Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma","volume":"282","author":"Caballero M","year":"2001","unstructured":"Caballero M, Borras T. Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma. Biochem Biophys Res Commun. 2001;282(3):662\u201370. Epub 2001\/06\/13. doi: 10.1006\/bbrc.2001.4624. PubMed PMID: 11401512.","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"ref39","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1128\/MCB.24.20.9019-9025.2004","article-title":"Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma","volume":"24","author":"Gould DB","year":"2004","unstructured":"Gould DB, Miceli-Libby L, Savinova OV, Torrado M, Tomarev SI, Smith RS, John SW. Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol. 2004;24(20):9019\u201325. Epub 2004\/10\/01. doi: 10.1128\/MCB.24.20.9019-9025.2004. PubMed PMID: 15456875; PMCID: PMC517885.","journal-title":"Mol Cell Biol"},{"issue":"22","key":"ref40","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1128\/MCB.21.22.7707-7713.2001","article-title":"Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function","volume":"21","author":"Kim BS","year":"2001","unstructured":"Kim BS, Savinova OV, Reedy MV, Martin J, Lun Y, Gan L, Smith RS, Tomarev SI, John SW, Johnson RL. Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function. Mol Cell Biol. 2001;21(22):7707\u201313. Epub 2001\/10\/18. doi: 10.1128\/MCB.21.22.7707-7713.2001. PubMed PMID: 11604506; PMCID: PMC99941.","journal-title":"Mol Cell Biol"},{"issue":"22","key":"ref41","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.1128\/MCB.01127-06","article-title":"Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma","volume":"26","author":"Gould DB","year":"2006","unstructured":"Gould DB, Reedy M, Wilson LA, Smith RS, Johnson RL, John SW. Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Mol Cell Biol. 2006;26(22):8427\u201336. Epub 2006\/09\/07. doi: 10.1128\/MCB.01127-06. PubMed PMID: 16954374; PMCID: PMC1636791.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"ref42","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1001\/archopht.119.11.1674","article-title":"Molecular and clinical evaluation of a patient hemizygous for TIGR\/MYOC","volume":"119","author":"Wiggs JL","year":"2001","unstructured":"Wiggs JL, Vollrath D. Molecular and clinical evaluation of a patient hemizygous for TIGR\/MYOC. Arch Ophthalmol. 2001;119(11):1674\u20138. Epub 2001\/11\/16. doi: 10.1001\/archopht.119.11.1674. PubMed PMID: 11709019.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"ref43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/hmg\/ddm001","article-title":"Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure","volume":"16","author":"Shepard AR","year":"2007","unstructured":"Shepard AR, Jacobson N, Millar JC, Pang IH, Steely HT, Searby CC, Sheffield VC, Stone EM, Clark AF. Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet. 2007;16(6):609\u201317. Epub 2007\/02\/24. doi: 10.1093\/hmg\/ddm001. PubMed PMID: 17317787.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"ref44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbrc.2003.10.162","article-title":"Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells","volume":"312","author":"Joe MK","year":"2003","unstructured":"Joe MK, Sohn S, Hur W, Moon Y, Choi YR, Kee C. Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun. 2003;312(3):592\u2013600. Epub 2003\/12\/19. doi: 10.1016\/j.bbrc.2003.10.162. PubMed PMID: 14680806.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.exer.2005.11.002","article-title":"Functional analysis of the glaucoma-causing TIGR\/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion","volume":"82","author":"Gobeil S","year":"2006","unstructured":"Gobeil S, Letartre L, Raymond V. Functional analysis of the glaucoma-causing TIGR\/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion. Exp Eye Res. 2006;82(6):1017\u201329. Epub 2006\/02\/10. doi: 10.1016\/j.exer.2005.11.002. PubMed PMID: 16466712.","journal-title":"Exp Eye Res"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1172\/JCI58183","article-title":"Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma","volume":"121","author":"Zode GS","year":"2011","unstructured":"Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, Grozdanic SD, Bugge K, Anderson MG, Clark AF, Stone EM, Sheffield VC. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest. 2011;121(9):3542\u201353. Epub 2011\/08\/09. doi: 10.1172\/JCI58183. PubMed PMID: 21821918; PMCID: PMC3163970.","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exer.2012.04.016","article-title":"Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice","volume":"100","author":"McDowell CM","year":"2012","unstructured":"McDowell CM, Luan T, Zhang Z, Putliwala T, Wordinger RJ, Millar JC, John SW, Pang IH, Clark AF. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice. Exp Eye Res. 2012;100:65\u201372. Epub 2012\/05\/12. doi: 10.1016\/j.exer.2012.04.016. PubMed PMID: 22575566; PMCID: PMC3612883.","journal-title":"Exp Eye Res"},{"issue":"46","key":"ref48","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.1523\/JNEUROSCI.3020-06.2006","article-title":"Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice","volume":"26","author":"Senatorov V","year":"2006","unstructured":"Senatorov V, Malyukova I, Fariss R, Wawrousek EF, Swaminathan S, Sharan SK, Tomarev S. Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J Neurosci. 2006;26(46):11903\u201314. doi: 10.1523\/JNEUROSCI.3020-06.2006. PubMed PMID: 17108164; PMCID: PMC6674879.","journal-title":"J Neurosci"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/21655979.2018.1470720","article-title":"CRISPR-Cas systems: ushering in the new genome editing era","volume":"9","author":"Perez Rojo F","year":"2018","unstructured":"Perez Rojo F, Nyman RKM, Johnson AAT, Navarro MP, Ryan MH, Erskine W, Kaur P. CRISPR-Cas systems: ushering in the new genome editing era. Bioengineered. 2018;9(1):214\u201321. Epub 2018\/07\/04. doi: 10.1080\/21655979.2018.1470720. PubMed PMID: 29968520; PMCID: PMC6067892.","journal-title":"Bioengineered"},{"issue":"6","key":"ref50","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu PD","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262\u201378. Epub 2014\/06\/07. doi: 10.1016\/j.cell.2014.05.010. PubMed PMID: 24906146; PMCID: PMC4343198.","journal-title":"Cell"},{"issue":"42","key":"ref51","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain A","year":"2017","unstructured":"Jain A, Zode G, Kasetti RB, Ran FA, Yan W, Sharma TP, Bugge K, Searby CC, Fingert JH, Zhang F, Clark AF, Sheffield VC. CRISPR-Cas9-based treatment of myocilin-associated glaucoma. Proc Natl Acad Sci U S A. 2017;114(42):11199\u2013204. Epub 2017\/10\/05. doi: 10.1073\/pnas.1706193114. PubMed PMID: 28973933; PMCID: PMC5651749.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref52","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1167\/iovs.09-4567","article-title":"Adenoviral gene transfer of active human transforming growth factor-beta2 elevates intraocular pressure and reduces outflow facility in rodent eyes","volume":"51","author":"Shepard AR","year":"2010","unstructured":"Shepard AR, Millar JC, Pang IH, Jacobson N, Wang WH, Clark AF. Adenoviral gene transfer of active human transforming growth factor-beta2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci. 2010;51(4):2067\u201376. Epub 2009\/12\/05. doi: 10.1167\/iovs.09-4567. PubMed PMID: 19959644.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3409-7_9","author":"Millar JC","year":"2023","unstructured":"Millar JC, Sundaresan Y, Zode GS, Clark AF. Viral Vector-Induced Ocular Hypertension in Mice. Methods Mol Biol. 2023;2708:77\u201397. doi: 10.1007\/978-1-0716-3409-7_9. PubMed PMID: 37558962."},{"issue":"Suppl 1","key":"ref54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/vop.12858","article-title":"Looking into the future: Gene and cell therapies for glaucoma","volume":"24","author":"Komaromy AM","year":"2021","unstructured":"Komaromy AM, Koehl KL, Park SA. Looking into the future: Gene and cell therapies for glaucoma. Vet Ophthalmol. 2021;24 Suppl 1:16\u201333. Epub 2021\/01\/08. doi: 10.1111\/vop.12858. PubMed PMID: 33411993; PMCID: PMC7979454.","journal-title":"Vet Ophthalmol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.preteyeres.2019.100799","article-title":"Inducible rodent models of glaucoma","volume":"75","author":"Pang IH","year":"2020","unstructured":"Pang IH, Clark AF. Inducible rodent models of glaucoma. Prog Retin Eye Res. 2020;75:100799. Epub 2019\/09\/27. doi: 10.1016\/j.preteyeres.2019.100799. PubMed PMID: 31557521; PMCID: PMC7085984.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"ref56","doi-asserted-by":"publisher","first-page":"e29533","DOI":"10.7759\/cureus.29533","article-title":"Ocular Gene Therapy: A Literature Review With Focus on Current Clinical Trials","volume":"14","author":"Wasnik VB","year":"2022","unstructured":"Wasnik VB, Thool AR. Ocular Gene Therapy: A Literature Review With Focus on Current Clinical Trials. Cureus. 2022;14(9):e29533. Epub 2022\/11\/01. doi: 10.7759\/cureus.29533. PubMed PMID: 36312652; PMCID: PMC9590687.","journal-title":"Cureus"},{"issue":"17\u201318","key":"ref57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1089\/hum.2022.159","volume":"33","author":"Cheng SY","year":"2022","unstructured":"Cheng SY, Punzo C. Update on Viral Gene Therapy Clinical Trials for Retinal Diseases. Hum Gene Ther. 2022;33(17\u201318):865\u201378. Epub 2022\/09\/09. doi: 10.1089\/hum.2022.159. PubMed PMID: 36074935; PMCID: PMC9639220.","journal-title":"Hum Gene Ther"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-019-0105-4","author":"Rodriguez-Estevez L","year":"2020","unstructured":"Rodriguez-Estevez L, Asokan P, Borras T. Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics. Gene Ther. 2020;27(3\u20134):127\u2009\u2013\u200942. Epub 20191014. doi: 10.1038\/s41434-019-0105-4. PubMed PMID: 31611639; PMCID: PMC7153980."},{"issue":"14","key":"ref59","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1167\/iovs.16-19610","article-title":"Expression of Mutant Myocilin Induces Abnormal Intracellular Accumulation of Selected Extracellular Matrix Proteins in the Trabecular Meshwork","volume":"57","author":"Kasetti RB","year":"2016","unstructured":"Kasetti RB, Phan TN, Millar JC, Zode GS. Expression of Mutant Myocilin Induces Abnormal Intracellular Accumulation of Selected Extracellular Matrix Proteins in the Trabecular Meshwork. Invest Ophthalmol Vis Sci. 2016;57(14):6058\u201369. Epub 2016\/11\/08. doi: 10.1167\/iovs.16-19610. PubMed PMID: 27820874; PMCID: PMC5102566.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"ref60","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1167\/iovs.11-8837","article-title":"Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma","volume":"53","author":"Zode GS","year":"2012","unstructured":"Zode GS, Bugge KE, Mohan K, Grozdanic SD, Peters JC, Koehn DR, Anderson MG, Kardon RH, Stone EM, Sheffield VC. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2012;53(3):1557\u201365. Epub 2012\/02\/14. doi: 10.1167\/iovs.11-8837. PubMed PMID: 22328638; PMCID: PMC3339917.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"ref61","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1167\/iovs.06-0296","article-title":"Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma","volume":"48","author":"Wordinger RJ","year":"2007","unstructured":"Wordinger RJ, Fleenor DL, Hellberg PE, Pang IH, Tovar TO, Zode GS, Fuller JA, Clark AF. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48(3):1191\u2013200. Epub 2007\/02\/28. doi: 10.1167\/iovs.06-0296. PubMed PMID: 17325163.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"ref62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136883","article-title":"A Novel Mouse Model of TGFbeta2-Induced Ocular Hypertension Using Lentiviral Gene Delivery","volume":"23","author":"Patil SV","year":"2022","unstructured":"Patil SV, Kasetti RB, Millar JC, Zode GS. A Novel Mouse Model of TGFbeta2-Induced Ocular Hypertension Using Lentiviral Gene Delivery. Int J Mol Sci. 2022;23(13). Epub 2022\/07\/10. doi: 10.3390\/ijms23136883. PubMed PMID: 35805889; PMCID: PMC9266301.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"ref63","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1167\/iovs.05-0781","article-title":"Noninvasive measurement of rodent intraocular pressure with a rebound tonometer","volume":"46","author":"Wang WH","year":"2005","unstructured":"Wang WH, Millar JC, Pang IH, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46(12):4617\u201321. Epub 2005\/11\/24. doi: 10.1167\/iovs.05-0781. PubMed PMID: 16303957.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ref64","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1038\/s41467-020-19352-1","article-title":"ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load","volume":"11","author":"Kasetti RB","year":"2020","unstructured":"Kasetti RB, Patel PD, Maddineni P, Patil S, Kiehlbauch C, Millar JC, Searby CC, Raghunathan V, Sheffield VC, Zode GS. ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load. Nat Commun. 2020;11(1):5594. Epub 2020\/11\/07. doi: 10.1038\/s41467-020-19352-1. PubMed PMID: 33154371; PMCID: PMC7644693.","journal-title":"Nat Commun"},{"issue":"5","key":"ref65","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143359","article-title":"Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin","volume":"6","author":"Kasetti RB","year":"2021","unstructured":"Kasetti RB, Maddineni P, Kiehlbauch C, Patil S, Searby CC, Levine B, Sheffield VC, Zode GS. Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin. JCI Insight. 2021;6(5). Epub 2021\/02\/05. doi: 10.1172\/jci.insight.143359. PubMed PMID: 33539326; PMCID: PMC8021112.","journal-title":"JCI Insight"},{"issue":"5","key":"ref66","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1172\/JCI69774","article-title":"Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma","volume":"124","author":"Zode GS","year":"2014","unstructured":"Zode GS, Sharma AB, Lin X, Searby CC, Bugge K, Kim GH, Clark AF, Sheffield VC. Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma. J Clin Invest. 2014;124(5):1956\u201365. Epub 2014\/04\/03. doi: 10.1172\/JCI69774. PubMed PMID: 24691439; PMCID: PMC4001532.","journal-title":"J Clin Invest"},{"key":"ref67","author":"Li H","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Genome Project Data Processing S. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139. Epub 20090608. doi: 10.1093\/bioinformatics\/btp352. PubMed PMID: 19505943; PMCID: PMC2723002."},{"key":"ref68","author":"McKenna A","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303. Epub 20100719. doi: 10.1101\/gr.107524.110. PubMed PMID: 20644199; PMCID: PMC2928508."},{"issue":"10","key":"ref69","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae S","year":"2014","unstructured":"Bae S, Park J, Kim JS. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 2014;30(10):1473\u20135. Epub 20140124. doi: 10.1093\/bioinformatics\/btu048. PubMed PMID: 24463181; PMCID: PMC4016707.","journal-title":"Bioinformatics"},{"issue":"1","key":"ref70","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1038\/s41467-022-34320-7","article-title":"A comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies","volume":"13","author":"Hoberecht L","year":"2022","unstructured":"Hoberecht L, Perampalam P, Lun A, Fortin JP. A comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies. Nat Commun. 2022;13(1):6568. Epub 20221102. doi: 10.1038\/s41467-022-34320-7. PubMed PMID: 36323688; PMCID: PMC9630310.","journal-title":"Nat Commun"},{"issue":"1","key":"ref71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson JT","year":"2011","unstructured":"Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u20136. doi: 10.1038\/nbt.1754. PubMed PMID: 21221095; PMCID: PMC3346182.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"ref72","doi-asserted-by":"publisher","first-page":"e0128759","DOI":"10.1371\/journal.pone.0128759","article-title":"Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat","volume":"10","author":"Bogner B","year":"2015","unstructured":"Bogner B, Boye SL, Min SH, Peterson JJ, Ruan Q, Zhang Z, Reitsamer HA, Hauswirth WW, Boye SE. Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat. PloS one. 2015;10(6):e0128759. Epub 2015\/06\/09. doi: 10.1371\/journal.pone.0128759. PubMed PMID: 26052939; PMCID: PMC4460001.","journal-title":"PloS one"},{"issue":"12","key":"ref73","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/gt.2017.85","article-title":"Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina","volume":"24","author":"Hickey DG","year":"2017","unstructured":"Hickey DG, Edwards TL, Barnard AR, Singh MS, de Silva SR, McClements ME, Flannery JG, Hankins MW, MacLaren RE. Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina. Gene Ther. 2017;24(12):787\u2013800. Epub 2017\/09\/06. doi: 10.1038\/gt.2017.85. PubMed PMID: 28872643; PMCID: PMC5746594.","journal-title":"Gene Ther"},{"issue":"8","key":"ref74","doi-asserted-by":"publisher","first-page":"e0182473","DOI":"10.1371\/journal.pone.0182473","article-title":"Single stranded adeno-associated virus achieves efficient gene transfer to anterior segment in the mouse eye","volume":"12","author":"Wang L","year":"2017","unstructured":"Wang L, Xiao R, Andres-Mateos E, Vandenberghe LH. Single stranded adeno-associated virus achieves efficient gene transfer to anterior segment in the mouse eye. PLoS One. 2017;12(8):e0182473. Epub 2017\/08\/02. doi: 10.1371\/journal.pone.0182473. PubMed PMID: 28763501; PMCID: PMC5538712.","journal-title":"PLoS One"},{"issue":"5","key":"ref75","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jgm.886","article-title":"Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells","volume":"8","author":"Borras T","year":"2006","unstructured":"Borras T, Xue W, Choi VW, Bartlett JS, Li G, Samulski RJ, Chisolm SS. Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells. J Gene Med. 2006;8(5):589\u2013602. Epub 2006\/03\/01. doi: 10.1002\/jgm.886. PubMed PMID: 16506246.","journal-title":"J Gene Med"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422X-10-74","article-title":"A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype","volume":"10","author":"Ellis BL","year":"2013","unstructured":"Ellis BL, Hirsch ML, Barker JC, Connelly JP, Steininger RJ, 3rd, Porteus MH. A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype. Virol J. 2013;10:74. Epub 2013\/03\/19. doi: 10.1186\/1743-422X-10-74. PubMed PMID: 23497173; PMCID: PMC3607841.","journal-title":"Virol J"},{"issue":"1","key":"ref77","doi-asserted-by":"publisher","first-page":"80","DOI":"10.22608\/APO.2016126","article-title":"The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs","volume":"6","author":"Borras T","year":"2017","unstructured":"Borras T. The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs. Asia Pac J Ophthalmol (Phila). 2017;6(1):80\u201393. Epub 2017\/02\/06. doi: 10.22608\/APO.2016126. PubMed PMID: 28161916; PMCID: PMC6005701.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the tropism of lentiviral vectors through pseudotyping","volume":"5","author":"Cronin J","year":"2005","unstructured":"Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther. 2005;5(4):387\u201398. Epub 2005\/08\/17. doi: 10.2174\/1566523054546224. PubMed PMID: 16101513; PMCID: PMC1368960.","journal-title":"Curr Gene Ther"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exer.2016.04.023","article-title":"Gene transfer to the outflow tract","volume":"158","author":"Dang Y","year":"2017","unstructured":"Dang Y, Loewen R, Parikh HA, Roy P, Loewen NA. Gene transfer to the outflow tract. Exp Eye Res. 2017;158:73\u201384. Epub 2016\/05\/02. doi: 10.1016\/j.exer.2016.04.023. PubMed PMID: 27131906; PMCID: PMC5083245.","journal-title":"Exp Eye Res"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081605","author":"Arsenijevic Y","year":"2022","unstructured":"Arsenijevic Y, Berger A, Udry F, Kostic C. Lentiviral Vectors for Ocular Gene Therapy. Pharmaceutics. 2022;14(8). Epub 2022\/08\/27. doi: 10.3390\/pharmaceutics14081605. PubMed PMID: 36015231; PMCID: PMC9414879."},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.153","author":"Balaggan KS","year":"2012","unstructured":"Balaggan KS, Ali RR. Ocular gene delivery using lentiviral vectors. Gene Ther. 2012;19(2):145\u2009\u2013\u200953. Epub 2011\/11\/05. doi: 10.1038\/gt.2011.153. PubMed PMID: 22052240."},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2018.03.001","author":"Keller KE","year":"2018","unstructured":"Keller KE, Bhattacharya SK, Borras T, Brunner TM, Chansangpetch S, Clark AF, Dismuke WM, Du Y, Elliott MH, Ethier CR, Faralli JA, Freddo TF, Fuchshofer R, Giovingo M, Gong H, Gonzalez P, Huang A, Johnstone MA, Kaufman PL, Kelley MJ, Knepper PA, Kopczynski CC, Kuchtey JG, Kuchtey RW, Kuehn MH, Lieberman RL, Lin SC, Liton P, Liu Y, Lutjen-Drecoll E, Mao W, Masis-Solano M, McDonnell F, McDowell CM, Overby DR, Pattabiraman PP, Raghunathan VK, Rao PV, Rhee DJ, Chowdhury UR, Russell P, Samples JR, Schwartz D, Stubbs EB, Tamm ER, Tan JC, Toris CB, Torrejon KY, Vranka JA, Wirtz MK, Yorio T, Zhang J, Zode GS, Fautsch MP, Peters DM, Acott TS, Stamer WD. Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. Exp Eye Res. 2018;171:164\u2009\u2013\u200973. Epub 2018\/03\/13. doi: 10.1016\/j.exer.2018.03.001. PubMed PMID: 29526795; PMCID: PMC6042513."},{"key":"ref83","first-page":"425","article-title":"Lentiviral mediated gene delivery to the anterior chamber of rodent eyes","volume":"11","author":"Challa P","year":"2005","unstructured":"Challa P, Luna C, Liton PB, Chamblin B, Wakefield J, Ramabhadran R, Epstein DL, Gonzalez P. Lentiviral mediated gene delivery to the anterior chamber of rodent eyes. Mol Vis. 2005;11:425\u201330. Epub 2005\/07\/01. PubMed PMID: 15988411; PMCID: PMC3152457.","journal-title":"Mol Vis"},{"issue":"1","key":"ref84","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1167\/iovs.09-3847","article-title":"Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys","volume":"51","author":"Buie LK","year":"2010","unstructured":"Buie LK, Rasmussen CA, Porterfield EC, Ramgolam VS, Choi VW, Markovic-Plese S, Samulski RJ, Kaufman PL, Borras T. Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. Invest Ophthalmol Vis Sci. 2010;51(1):236\u201348. Epub 2009\/08\/18. doi: 10.1167\/iovs.09-3847. PubMed PMID: 19684004; PMCID: PMC2869048.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ref85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.virol.2004.04","article-title":"Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors","volume":"325","author":"Everett RS","year":"2004","unstructured":"Everett RS, Evans HK, Hodges BL, Ding EY, Serra DM, Amalfitano A. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors. Virology. 2004;325(1):96\u2013105. Epub 2004\/07\/03. doi: 10.1016\/j.virol.2004.04.032. PubMed PMID: 15231389.","journal-title":"Virology"},{"issue":"6","key":"ref86","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3980\/j.issn.2222-3959.2014.06","article-title":"Gene transfer to human trabecular meshwork cells in vitro and ex vivo using HIV-based lentivirus","volume":"7","author":"Xiang Y","year":"2014","unstructured":"Xiang Y, Li B, Wang JM, Li GG, Zhang H, Manyande A, Tian XB. Gene transfer to human trabecular meshwork cells in vitro and ex vivo using HIV-based lentivirus. Int J Ophthalmol. 2014;7(6):924\u20139. Epub 2014\/12\/30. doi: 10.3980\/j.issn.2222-3959.2014.06.02. PubMed PMID: 25540740; PMCID: PMC4270982.","journal-title":"Int J Ophthalmol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnmol.2020.00148","article-title":"Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases","volume":"13","author":"Rittiner JE","year":"2020","unstructured":"Rittiner JE, Moncalvo M, Chiba-Falek O, Kantor B. Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases. Front Mol Neurosci. 2020;13:148. Epub 2020\/09\/10. doi: 10.3389\/fnmol.2020.00148. PubMed PMID: 32903507; PMCID: PMC7437156.","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"ref88","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nbt.3404","article-title":"Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition","volume":"33","author":"Kleinstiver BP","year":"2015","unstructured":"Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol. 2015;33(12):1293\u20138. Epub 2015\/11\/03. doi: 10.1038\/nbt.3404. PubMed PMID: 26524662; PMCID: PMC4689141.","journal-title":"Nat Biotechnol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin EV","year":"2017","unstructured":"Koonin EV, Makarova KS, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol. 2017;37:67\u201378. Epub 2017\/06\/13. doi: 10.1016\/j.mib.2017.05.008. PubMed PMID: 28605718; PMCID: PMC5776717.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"ref90","doi-asserted-by":"publisher","first-page":"21474","DOI":"10.1038\/s41598-020-78450-8","article-title":"Efficient viral delivery of Cas9 into human safe harbor","volume":"10","author":"Hayashi H","year":"2020","unstructured":"Hayashi H, Kubo Y, Izumida M, Matsuyama T. Efficient viral delivery of Cas9 into human safe harbor. Sci Rep. 2020;10(1):21474. Epub 2020\/12\/10. doi: 10.1038\/s41598-020-78450-8. PubMed PMID: 33293588; PMCID: PMC7722726.","journal-title":"Sci Rep"},{"issue":"6","key":"ref91","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/gkv137","article-title":"A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture","volume":"43","author":"O'Geen H","year":"2015","unstructured":"O'Geen H, Henry IM, Bhakta MS, Meckler JF, Segal DJ. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res. 2015;43(6):3389\u2013404. Epub 20150220. doi: 10.1093\/nar\/gkv137. PubMed PMID: 25712100; PMCID: PMC4381059.","journal-title":"Nucleic Acids Res"},{"issue":"7681","key":"ref92","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli NM","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature. 2017;551(7681):464\u201371. Epub 20171025. doi: 10.1038\/nature24644. PubMed PMID: 29160308; PMCID: PMC5726555.","journal-title":"Nature"},{"issue":"2","key":"ref93","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota S","year":"2022","unstructured":"Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB, Osborn MJ, Musunuru K, Palczewski K, Liu DR. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022;185(2):250\u201365 e16. Epub 20220111. doi: 10.1016\/j.cell.2021.12.021. PubMed PMID: 35021064; PMCID: PMC8809250.","journal-title":"Cell"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.omtn.2022.08.026","article-title":"Effective gene therapy of Stargardt disease with PEG-ECO\/pGRK1-ABCA4-S\/MAR nanoparticles","volume":"29","author":"Sun D","year":"2022","unstructured":"Sun D, Sun W, Gao SQ, Lehrer J, Naderi A, Wei C, Lee S, Schilb AL, Scheidt J, Hall RC, Traboulsi EI, Palczewski K, Lu ZR. Effective gene therapy of Stargardt disease with PEG-ECO\/pGRK1-ABCA4-S\/MAR nanoparticles. Mol Ther Nucleic Acids. 2022;29:823\u201335. Epub 20220824. doi: 10.1016\/j.omtn.2022.08.026. PubMed PMID: 36159595; PMCID: PMC9463552.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"39","key":"ref95","doi-asserted-by":"publisher","first-page":"e2210104119","DOI":"10.1073\/pnas.2210104119","article-title":"Precision genome editing in the eye","volume":"119","author":"Suh S","year":"2022","unstructured":"Suh S, Choi EH, Raguram A, Liu DR, Palczewski K. Precision genome editing in the eye. Proc Natl Acad Sci U S A. 2022;119(39):e2210104119. Epub 20220919. doi: 10.1073\/pnas.2210104119. PubMed PMID: 36122230; PMCID: PMC9522375.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3\u20134","key":"ref96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41434-021-00282-6","article-title":"Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system","volume":"29","author":"O'Keeffe Ahern J","year":"2022","unstructured":"O'Keeffe Ahern J, Lara-Saez I, Zhou D, Murillas R, Bonafont J, Mencia A, Garcia M, Manzanares D, Lynch J, Foley R, Xu Q, Sigen A, Larcher F, Wang W. Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system. Gene Ther. 2022;29(3\u20134):157\u201370. Epub 20210806. doi: 10.1038\/s41434-021-00282-6. PubMed PMID: 34363036; PMCID: PMC9013665.","journal-title":"Gene Ther"},{"issue":"3","key":"ref97","doi-asserted-by":"publisher","first-page":"eabj6901","DOI":"10.1126\/sciadv.abj6901","article-title":"In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy","volume":"8","author":"Han JP","year":"2022","unstructured":"Han JP, Kim M, Choi BS, Lee JH, Lee GS, Jeong M, Lee Y, Kim EA, Oh HK, Go N, Lee H, Lee KJ, Kim UG, Lee JY, Kim S, Chang J, Lee H, Song DW, Yeom SC. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy. Sci Adv. 2022;8(3):eabj6901. Epub 20220121. doi: 10.1126\/sciadv.abj6901. PubMed PMID: 35061543; PMCID: PMC8782450.","journal-title":"Sci Adv"},{"key":"ref98"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3740880\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3740880\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T15:22:59Z","timestamp":1711380179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3740880\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":98,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3740880\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-024-57286-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,12,19]]},"subtype":"preprint"}}